Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery

作者: E.V. Kilpatrick , T.M. Cocks

DOI: 10.1111/J.1476-5381.1994.TB13110.X

关键词:

摘要: 1. The possible roles of endothelial and smooth muscle cell hyperpolarization nitric oxide (NO) in endothelium-dependent relaxation were examined isolated rings pig right coronary artery. 2. effects prevented with high K+ (30-125 mM), isotonic Krebs solutions. Functional antagonism due to K(+)-induced contraction was 0.3 microM nifedipine (in all treatments, for consistency). All contracted the thromboxane-mimetic U46619, (1-100 nM) bring them an initial active force within 30-50% maximum contraction. 3. High had no on sensitivity (EC50) or time course (substance P, SP; bradykinin, BK; calcimycin, A23187) -independent (sodium nitroprusside, SNP) agents. Maximum relaxations (Rmax) SP, BK A23187 reduced significantly by approximately 20% but only 125 mM K+. 4. In normal solution (5.9 NG-nitro-L-arginine (L-NOARG; 100 microM) caused 40%, reduction Rmax SNP respectively. EC50s SP decreased two fold whereas that increased ten fold. At concentrations L-NOARG (100 complete inhibition those unaffected. 5. (30 mM) unmasked potent concentration-dependent L-NOARG. 10 L-NOARG, responses abolished at higher (1-10 small significant contractions observed. 6. N0-monomethyl-L-arginine (L-NMMA) similar presence 30 except (40%) achieved MicroM L-NMMA this not either 1000 L-NMMA. K+, (1000 MicroM) EC50 fold, without affecting Rmax.7. choline+ (25, 75 also direct effect SP,but like enabled inhibit these completely. Neither charybdotoxin(30 nor substitution 25 NaCl 50 sucrose any block MicroM).8. conclusion, most if artery vitro is NO, can supplement 60% -80% response NO synthesis blocked. Multiple endothelium-derived factors could explain heterogeneity degree L-arginine analogues, constitute important 'back-up' mechanisms control arterial diameter.

参考文章(44)
M.A. Marletta, Nitric oxide synthase structure and mechanism. Journal of Biological Chemistry. ,vol. 268, pp. 12231- 12234 ,(1993) , 10.1016/S0021-9258(18)31375-9
Carl Nathan, Nitric oxide as a secretory product of mammalian cells. The FASEB Journal. ,vol. 6, pp. 3051- 3064 ,(1992) , 10.1096/FASEBJ.6.12.1381691
S Najibi, R A Cohen, J J Palacino, C L Cowan, Potassium channel-mediated relaxation to acetylcholine in rabbit arteries. Journal of Pharmacology and Experimental Therapeutics. ,vol. 266, pp. 1482- 1489 ,(1993)
R M Palmer, S Moncada, E A Higgs, NITRIC OXIDE: PHYSIOLOGY, PATHOPHYSIOLOGY, AND PHARMACOLOGY Pharmacological Reviews. ,vol. 43, pp. 109- 142 ,(1991)
S P Olesen, P F Davies, D E Clapham, Muscarinic-activated K+ current in bovine aortic endothelial cells. Circulation Research. ,vol. 62, pp. 1059- 1064 ,(1988) , 10.1161/01.RES.62.6.1059
M. Hecker, J.A. Mitchell, H.J. Harris, M. Katsura, C. Thiemermann, J.R. Vane, NG-monomethyl-L-arginine but not Nω-nitro-L-arginine is metabolized by endottielial cells to L-citrulline European Journal of Pharmacology. ,vol. 183, pp. 648- 649 ,(1990) , 10.1016/0014-2999(90)93576-C
S. Moncada, D. D. Rees, R. Schulz, R. M. Palmer, Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 2166- 2170 ,(1991) , 10.1073/PNAS.88.6.2166